2024 Heart Failure update: NICE guideline

This video makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". Please note that the content on this channel reflects my professional interpretation/summary of the guidance and that I am in no way affiliated with, employed by or funded/sponsored by NICE.
My name is Fernando Florido and I am a General Practitioner in the United Kingdom. In this episode, I go through the NICE guideline [NG106] on Chronic Heart Failure in adults, always focusing on what is relevant in Primary Care only.
I am not giving medical advice; this video is intended for health care professionals; it is only my summary and my interpretation of the guidelines and you must use your clinical judgement.
Tracks:
00:00 - Introduction and welcome
00:20 - Diagnosis
03:33 - Diagnosis visual summary
04:58 - Management of all types of CHF
06:50 - Management of HFrEF
10:09 - Monitoring
11:02 - Management visual summary
13:13 - Thank you and good-bye
There is a podcast version of this and other videos that you can access here:
Primary Care guidelines podcast:
• Redcircle: redcircle.com/shows/primary-c...
• Spotify: open.spotify.com/show/5BmqS0O...
• Apple podcasts: podcasts.apple.com/gb/podcast...
There is a RUclips version of this and other videos that you can access here:
• The Practical GP RUclips Channel:
/ @practicalgp
The resources consulted can be found here:
Chronic Heart Failure in adults: diagnosis and management - NICE guideline [NG106]:
• www.nice.org.uk/guidance/ng106
The visual summary for the diagnosis of chronic heart failure can be found here:
• www.nice.org.uk/guidance/ng10...
The visual summary for the management of chronic heart failure can be found here:
• www.nice.org.uk/guidance/ng10...

[@NihalPeeris]

Good summary 👍

[@practicalgp]

Thank you very much for your support. It helps a lot 🙏

[@glowaesthetics9801]

Nicely summarised (no pun intended...) were there any changes to previous guidance?

[@practicalgp]

Thank you nicely 😜. I really appreciate your support. No major changes from the previous guidance as such but they make references to the technology appraisals on SGLT2 inhibitors for heart failure which have changed relatively recently with dapaglifozin and empaglifozin being recommended for both HFrEF and HFpEF